相关实验视频

Updated: Sep 10, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

使用in silico方法对多目标胰岛素模拟抗糖尿病的表征

Anas Bilal¹, Ghulam Mustafa¹

¹Department of Biochemistry, Government College University Faisalabad, Faisalabad, Pakistan.

|August 19, 2025

概括

植物性低血糖 (HGP) 显示出糖尿病治疗的前景. 计算分析确定了P2和P6与关键糖尿病受体强有力的结合,这表明了潜在的治疗应用.

科学领域:

生物化学生化学
计算生物学计算生物学
药理学药理学是指药理学的学科.

背景情况:

糖尿病是一种重要的全球健康挑战,口服治疗选择有限.
目前的合成抗糖尿病药物和胰岛素都有局限性,包括副作用和管理困难.
生物活性因其有益的生理作用而提供了潜在的替代品.

研究的目的:

识别和描述具有潜在抗糖尿病活性的植物性低血糖 (HGP).
使用计算方法研究HGPs与糖尿病关键蛋白质受体的结合相互作用.
确定用于开发有效糖尿病治疗的新候选人.

主要方法:

用蛋白对接模拟来分析7个HGP与10个选定的糖尿病受体蛋白的结合模式.
哈德克分数和结合能被计算出来以评估受体相互作用.
进行了分子动力学模拟,以评估受体复合体随时间的稳定性.

主要成果:

P2和P6表现出对目标受体最有利的结合得分和模式.
P2对马尔塔酶-葡萄糖胺酶和葡萄糖载体1 (GLUT1) 产生强烈的结合.
P6对胰岛素样生长因子1受体和胰腺α-氨基酶显著结合,在分子动力学模拟中观察到稳定的相互作用.

结论:

该计算研究验证了已识别的HGP对选定的糖尿病蛋白的疗效.
P2和P6是开发胰岛素模仿性抗糖尿病药物的有希望的候选者.
进一步的体内和体外验证是必要的,以确认它们对糖尿病的治疗潜力.

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

相关概念视频

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Insulin: Biosynthesis, Chemistry, and Preparation

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...